On 2025-05-15, RenovoRx, Inc. (RNXT) announced earnings per share of $-0.08 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.08.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.08 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.08 | $-0.08 |
| 2025-03-31 | 2024-12-31 | -- | $-0.12 |
| 2024-11-13 | 2024-09-30 | $-0.12 | $-0.10 |
| 2024-08-13 | 2024-06-30 | -- | $-0.10 |
| 2024-05-10 | 2024-03-31 | -- | $-0.07 |
| 2024-04-01 | 2023-12-31 | -- | $-0.17 |
| 2023-11-13 | 2023-09-30 | $-0.30 | $-0.27 |
| 2023-08-16 | 2023-06-30 | $-0.25 | $-0.22 |
| 2023-05-15 | 2023-03-31 | $-0.25 | $-0.36 |
| 2023-03-02 | 2022-12-31 | $-0.26 | $-0.23 |
| 2022-11-14 | 2022-09-30 | $-0.27 | $-0.24 |
| 2022-08-15 | 2022-06-30 | $-0.26 | $-0.29 |
| 2022-05-16 | 2022-03-31 | $-0.25 | $-0.33 |
| 2022-03-30 | 2021-12-31 | $-0.18 | $-0.12 |
| 2021-11-15 | 2021-09-30 | $-0.29 | $-0.27 |